A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if ensifentrine is safe and effective for the
treatment of patients with moderate to severe Chronic Obstructive Pulmonary Disease (COPD).